Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group

Katsivelos, N., Spyrou, N., Weber, D., Vasova, I., Ayuk, F., Choe, H., Hogan, W., DeFilipp, Z., Qayed, M., Etra, A. M., Sandhu, K., Kraus, S., Olson, T., Hexner, E., Aguayo-Hiraldo, P., Reshef, R., Ullrich, E., Schechter, T., Kitko, C., … Levine, J. E. (2024). Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2024.10.012
Authors:
Nikolaos Katsivelos
Nikolaos Spyrou
Daniela Weber
Ingrid Vasova
Francis Ayuk
Hannah Choe
William Hogan
Zachariah DeFilipp
Muna Qayed
Aaron M Etra
Karam Sandhu
Sabrina Kraus
Tim Olson
Elizabeth Hexner
Paibel Aguayo-Hiraldo
Ran Reshef
Evelyn Ullrich
Tal Schechter
Carrie Kitko
Chantiya Chanswangphuwana
Pietro Merli
Yu Akahoshi
Janna Baez
Gilbert Eng
Rahnuma Beheshti
Steven Kowalyk
George Morales
Ioannis Evangelos Louloudis
Rachel Young
Ernst Holler
Ryotaro Nakamura
James L M Ferrara
John E Levine
Affiliated Authors:
Ran Reshef
Columbia Affiliation:
Author Keywords:
acute gvhd
biomarker
treatment
immunosuppression
elink
Publication Type:
Article
Unique ID:
10.1016/j.jtct.2024.10.012
PMID:
39667999
DOI:
10.1016/j.jtct.2024.10.012
Journal:
Transplantation and Cellular Therapy
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: